Jen-Leih Wu

This inventor holds 8 USPTO granted patents and 1 published patent application. Top assignees: Academia Sinica, National Taiwan Ocean University. Active years: 2000-2013.

USPTO Granted Patents = 8 (Patent Applications = 1)

% Patents Active = 37.5

Average Co-Inventor Count = 2.3

ph-index = 1

Forward Citations = 18(Granted Patents)

Company Filing History:

National Taiwan Ocean University

patents

where one patent can have more than one assignee

Years Active: 2000-2013

Loading Chart...

8 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 8383880 - Infertility control of genetically modified fish (2013-02-26),

2. 7670836 - [object Object] (2010-03-02),

3. 7411060 - Transgenic fish germline expression driven by liver fatty acid binding (L-FABP) gene promoter and applications thereof (2008-08-12),

4. 7008621 - Regulation of apoptosis in aquatic organisms by aquabirnavirus (2006-03-07),

5. 6630456 - Regulation of apoptosis in aquatic organisms by aquabirnavirus (2003-10-07),

6. 6235874 - Production of biologically active recombinant insulin-like growth factor II polypeptides (2001-05-22),

7. 6207817 - Fish insulin-like growth factor II promoter (2001-03-27),

8. 6010882 - Production of biologically active recombinant insulin-like growth factor (2000-01-04),

Title: Innovations of Inventor Jen-Leih Wu

Introduction

Jen-Leih Wu is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the development of genetically modified organisms. With a total of 8 patents to his name, Wu's work has garnered attention for its innovative approaches to addressing various biological challenges.

Latest Patents

One of Wu's latest patents focuses on infertility control in genetically modified fish. This invention discloses a method for inducing male and/or female infertility in genetically modified fish. The method involves generating a GM fish with a specific phenotype and/or genotype by incorporating a foreign transgene linked to a fish gonad-specific promoter. The transgene includes a suicide gene that can be activated through specific treatments, leading to infertility in the GM fish. Another notable invention is the antimicrobial peptide monodoncin, which is isolated and purified for mass production using molecular cloning techniques. Monodoncin exhibits a wide range of bacteriostatic and bactericidal effects on both Gram-negative and Gram-positive bacteria, as well as fungicidal activities. This peptide can be used in combination with conventional antibiotics to enhance their therapeutic effects.

Career Highlights

Throughout his career, Jen-Leih Wu has worked with esteemed institutions such as Academia Sinica and National Taiwan Ocean University. His research has significantly advanced the understanding of genetic modifications and their applications in various fields.

Collaborations

Wu has collaborated with notable colleagues, including Jyh-Yih Chen and Jiann-Ruey Hong. These partnerships have contributed to the success of his innovative projects and patents.

Conclusion

Jen-Leih Wu's contributions to biotechnology through his patents and research have made a lasting impact in the field. His innovative methods for controlling infertility in genetically modified fish and developing antimicrobial peptides showcase his commitment to advancing scientific knowledge and applications.